article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Observational studies should not be seen as competition to RCTs but as complementary to them, and as a sector we need to stop working in silos and develop an integrated and more comprehensive approach to evidence-based decision-making in safeguarding public health. EMA/95098/2010. Internet] European Medicines Agency. cited Dec2023].

Safety 113
article thumbnail

Comparison of Humira biosimilars in the US and Europe

Pharmaceutical Technology

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. The biosimilar market in the US may progress differently this time.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Highly Cited Researchers 2021: How nations and institutions foster exceptional performance

Clarivate

These highly cited papers rank in the top 1% by citations for field and year from 2010 – 2020. We’re pleased to showcase some institutions that excel in a competitive global environment, supporting their Highly Cited Researchers in a way that encourages collaboration, facilitates career growth and accelerates highly innovative research.

article thumbnail

Global comparator data signal “alarm bells” for UK Government, says APBI

pharmaphorum

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.

article thumbnail

Breaking through the forecasting fog – 3 trends that will impact critical medicine supply in 2023

pharmaphorum

Demand has also increased due to changes in prescribing protocols, leading to a higher underlying number of prescriptions for certain antibiotic medicines. He previously held regional leadership roles at Sandoz between 2005 and 2010. One prediction is that we will see more tentative moves in this direction. The impact is two-fold.

article thumbnail

Traditional approaches to growth in biopharma are no longer sustainable

pharmaphorum

Such inorganic growth is no longer viable, argues Pervaise Khan, Accenture’s UK Life Sciences Lead. Through our recent report, Scientific innovations for more sustainable growth , we analysed over 300 M&A deals made by the world’s top 30 biopharma companies between 2010–2021. About the Author.

article thumbnail

Top 10 Best Telemedicine Companies in the USA

Medico Reach

MDLive is a leading virtual on-demand healthcare service provider. HealthTap Headquarters: California Revenue: $65M Employee Size: 51-200 employees Website URL: [link] Since 2010, Health Tap has been one of the top healthcare platforms, providing the public with the greatest medical guidance.

Doctors 40